Queueing network modelling and lead time compression of pharmaceutical drug development

International Journal of Production Research

Volumn 39, Issue 2, 2001, Pages 395-412

  Viswanadham, N ^a   Narahari, Y ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; MATHEMATICAL MODELS; OPTIMIZATION; PERSONNEL; PLANNING; PROJECT MANAGEMENT; QUEUEING NETWORKS; RESOURCE ALLOCATION; SCHEDULING; TIME AND MOTION STUDY;

LEAD TIME; PHARMACEUTICAL DRUG DEVELOPMENT; QUEUEING NETWORK MODEL; TASK EXECUTION TIMES;

PRODUCT DEVELOPMENT;

EID: 0035916061     PISSN: 00207543     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207540010004304     Document Type: Article

References (33)

1. Adler, P. S., Mandelbaum, A., Nguyen, V. and Schwerer, E., 1994, From project to process management: Strategies for improving development cycle time. Technical report, Sloan School of Management, Massachusetts Institute of Technology.
2. Adler, P. S., Mandelbaum, A., Nguyen, V. and Schwerer, E., 1995, From project to process management: An empirically-based framework for analyzing product development time. Management Science, 41, 458-484.
3. Adler, P. S., Mandelbaum, A., Nguyen, V. and Schwerer, E., 1996, Getting the most out of your product development process. Harvard Business Review, 22, 134-152.
4. Basa, F. and Allen, T. J., 1994, Managing the drug development process: A preliminary report on project management in the pharmaceutical industry. Technical Report 9-94, Sloan School of Management, Massachusetts Institute of Technology.
5. Bourland, K., 1994, Cellular production at spartan. Technical report, Teaching Case, Tuck School of Business, Dartmouth College Hanover, New Hampshire.
6. Bourland, K. and Suri, R., 1992, Spartan industries. Technical report, Case Study, Tuck School of Business, Dartmouth College, Hanover, New Hampshire.
7. Cohen, M. A., Eliashberg, J. and Ho, T. H., 1997, New product development: The performance and time-to-market tradeoff. Management Science, 42, 173-186.
8. Gatenby, D. A., Lee, P. M., Howard, R. E., Hushyar, K., Layendecker, R. and Wesner, J., 1994, Concurrent engineering: an enabler for fast, high quality product realization. AT & T Technical Journal, pp. 34-47.
9. Harrison, J. M. and Loch, C. H., 1995, Operations management and reengineering. Technical report, The Graduate School of Business, Stanford University.
10. Hauptman, O. and Hirji, K. K., 1996, The influence of process concurrency on project outcomes in product development: An empirical study of cross-functional teams. IEEE Transactions on Engineering Management, 43, 153-164.
11. Hopp, W. J. and Spearman, M. L., 1996, Factory Physics: Foundations of Manufacturing Management (Irwin: McGraw-Hill).
12. Hopp, W. J. Spearman, M. L. and Woodruff, D. L., 1990. Practical strategies for lead time reduction. Manufacturing Review, 3, 78-84.
13. Knoop, S. J. and Worden, D. E., 1988. The pharmaceutical drug development process: An overview. Drug Information Journal, 22, 259-268.
14. Kumar, P. R., 1993, Re-Entrant lines. Queueing Systems: Theory and Applications, 13, 87-110.
15. Lu, S. H., Ramaswamy, D. and Kumar, P. R., 1994, Efficient scheduling policies to reduce mean and variance of cycle-time in semiconductor manufacturing plants. IEEE Transactions on Semiconductor Manufacturing, 7, 374-388.
16. Narahari, Y. and Khan, L. M., 1997, Modeling re-entrant manufacturing systems with inspections. Journal of Manufacturing Systems, 16, 367-378.
17. Narahari, Y., Viswanadham., N. and Kiran Kumar, V., 1999, Lead time modeling and acceleration of new product development. IEEE Transactions on Robotics and Automation, 15, 882-896.
18. Sarantapoulos, P. D., Altiok, T. and Elsayed, E. A., 1995, Manufacturing in the pharmaceutical industry. Journal of Manufacturing Systems, 14, 452-467.
19. Smith, P. and Reinertsen, D., 1991, Developing Products in Half the Time (New York: Van Nostrand Reinhold).
20. Suri, R., 1996, Using queueing networks to support quick response manufacturing. Proceedings of the IIE Conference of the Institute of Industrial Engineers, USA, pp. 603-609.
21. Viswanadham, N. and Narahari, Y., 1992, Performance Modeling of Automated Manufacturing Systems (Englewood Cliffs, NJ: Prentice Hall).
22. WEB 1 World Wide Web, http://www.pfizer.com/pfizerinc/about/pubs/journal/opportunity
23. WEB 2 World Wide Web, http://www.hcnor.com/rx-help/approval.html
24. WEB 3 World Wide Web, http://www.pharma.org/charts/approval.html
25. WEB 4 World Wide Web, http://www.wabio.com/dis/drug-approv.html
26. WEB 5 World Wide Web, http://www.mhsource.com
27. WEB 6 World Wide Web, http://www.allp.com/drug-dev.htm
28. WEB 7 World Wide Web, http://www.critpath.org/research/process.htm
29. WEB 8 World Wide Web, http://www.fda.gov/fdac/special/newdrug/speeding.html
30. WEB 9 World Wide Web, http://www.fda.gov/cder/rdml
31. WHEELWRIGHT, S. C. and CLARK, K. B., 1992, Revolutionizing Product Development: Quantum Leaps in Speed, Efficiency and Quality (New York: The Free Press).
32. Yevich, J. P., 1991, Drug development: From discovery to marketing. In A Text-book of Drug Design and Development (Reading, MA: Harwood), pp. 606-630.
33. Zirger, B. J. and Hartley, J. L., 1996, The effect of acceleration techniques on product development time. IEEE Transactions on Engineering Managements, 43, 143-150.